Viral vector vaccines

Viral vector vaccines

Over the past two years, the SARS-CoV-2 pandemic has highlighted the impact that emerging pathogens can have on global health. The development of new and effective vaccine technologies is vital in the fight against such threats. Viral vectors are a relatively new vaccine platform that relies on reco...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	McCann, N, O'Connor, D, Lambe, T, Pollard, AJ
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Elseveir 2022

Παρόμοια τεκμήρια

Clinical advances in viral-vectored influenza vaccines
ανά: Sebastian, S, κ.ά.
Έκδοση: (2018)

Clinical Advances in Viral-Vectored Influenza Vaccines
ανά: Sarah Sebastian, κ.ά.
Έκδοση: (2018-05-01)

Clinical development of viral vectored vaccines against MERS-COV
ανά: Ewer, K, κ.ά.
Έκδοση: (2018)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
ανά: Sheerin, D, κ.ά.
Έκδοση: (2021)

Viral vectors as vaccine platforms: from immunogenicity to impact
ανά: Ewer (nee Russell), K, κ.ά.
Έκδοση: (2016)

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
ανά: Green, C, κ.ά.
Έκδοση: (2023)

Towards paratyphoid control: the vital role of the challenge model
ανά: McCann, N, κ.ά.
Έκδοση: (2024)

Viral vectors for malaria vaccine development.
ανά: Li, S, κ.ά.
Έκδοση: (2007)

Characterizing vaccine responses using host genomic and transcriptomic analysis.
ανά: O'Connor, D, κ.ά.
Έκδοση: (2013)

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus
ανά: Sheerin, D, κ.ά.
Έκδοση: (2022)

Developing viral vectored vaccines for MAGE-expressing tumours
ανά: McAuliffe, J
Έκδοση: (2020)

The use of viral vectors in vaccine development
ανά: Tatianna Travieso, κ.ά.
Έκδοση: (2022-07-01)

Replicon RNA Viral Vectors as Vaccines
ανά: Kenneth Lundstrom
Έκδοση: (2016-11-01)

Developments in Viral Vector-Based Vaccines
ανά: Takehiro Ura, κ.ά.
Έκδοση: (2014-07-01)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
ανά: Bissett, C, κ.ά.
Έκδοση: (2024)

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
ανά: Dylan Sheerin, κ.ά.
Έκδοση: (2021-10-01)

Utilization of Viral Vector Vaccines in Preparing for Future Pandemics
ανά: Kimberly A. Hofmeyer, κ.ά.
Έκδοση: (2022-03-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
ανά: Arunkumar, G, κ.ά.
Έκδοση: (2019)

Viral vectors as vaccine platforms: Deployment in sight
ανά: Rollier, C, κ.ά.
Έκδοση: (2011)

Viral vectors as vaccine platforms: deployment in sight.
ανά: Rollier, C, κ.ά.
Έκδοση: (2011)

Viral Vectors for COVID-19 Vaccine Development
ανά: Kenneth Lundstrom
Έκδοση: (2021-02-01)

Viral Vector Vaccines against Bluetongue Virus
ανά: Luis Jiménez-Cabello, κ.ά.
Έκδοση: (2020-12-01)

Novel viral vector vaccines for tropical infections
ανά: Rampling, T
Έκδοση: (2017)

The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines
ανά: Naina McCann, κ.ά.
Έκδοση: (2024-08-01)

The use of systems biology and immunological big data to guide vaccine development.
ανά: Blohmke, C, κ.ά.
Έκδοση: (2015)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
ανά: McMahon, M, κ.ά.
Έκδοση: (2019)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
ανά: Kapulu, MC
Έκδοση: (2014)

RNA2HLA: HLA-based quality control of RNA-seq datasets
ανά: Chelysheva, I, κ.ά.
Έκδοση: (2021)

Vaccinating the Vulnerable: How Do We Protect Those Experiencing Homelessness?
ανά: Lucy Jane McCann
Έκδοση: (2021-08-01)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
ανά: Tully, C, κ.ά.
Έκδοση: (2017)

Research advances in replication-deficient viral vector vaccines
ανά: Junna Wang, κ.ά.
Έκδοση: (2025-03-01)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
ανά: Dulce Mata-Espinosa, κ.ά.
Έκδοση: (2023-10-01)

Baculovirus expression vector system for production of viral vaccines /
ανά: 300419 Vlak, J. M., κ.ά.

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
ανά: Marta Ulaszewska, κ.ά.
Έκδοση: (2023-01-01)

Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination
ανά: Pischedda, S, κ.ά.
Έκδοση: (2021)

Self-reported adverse events in adolescents aged 13-18 years after mass vaccination with pertussis-containing vaccine, following a school outbreak.
ανά: McCann, L, κ.ά.
Έκδοση: (2013)

Self-reported adverse events in adolescents aged 13-18 years after mass vaccination with pertussis-containing vaccine, following a school outbreak
ανά: McCann, L, κ.ά.
Έκδοση: (2013)

Searching for the human genetic factors standing in the way of universally effective vaccines.
ανά: Mentzer, A, κ.ά.
Έκδοση: (2015)

The effect of H1N1 vaccination on serum miRNA expression in children: A tale of caution for microRNA microarray studies
ανά: Drury, R, κ.ά.
Έκδοση: (2019)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
ανά: Ewer (nee Russell), K, κ.ά.
Έκδοση: (2017)